1. Home
  2. PRTC vs CLMB Comparison

PRTC vs CLMB Comparison

Compare PRTC & CLMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRTC
  • CLMB
  • Stock Information
  • Founded
  • PRTC 2015
  • CLMB 1982
  • Country
  • PRTC United States
  • CLMB United States
  • Employees
  • PRTC N/A
  • CLMB N/A
  • Industry
  • PRTC Biotechnology: Pharmaceutical Preparations
  • CLMB Retail: Computer Software & Peripheral Equipment
  • Sector
  • PRTC Health Care
  • CLMB Technology
  • Exchange
  • PRTC Nasdaq
  • CLMB Nasdaq
  • Market Cap
  • PRTC 402.3M
  • CLMB 457.3M
  • IPO Year
  • PRTC N/A
  • CLMB N/A
  • Fundamental
  • Price
  • PRTC $16.74
  • CLMB $106.47
  • Analyst Decision
  • PRTC Buy
  • CLMB Buy
  • Analyst Count
  • PRTC 1
  • CLMB 1
  • Target Price
  • PRTC $45.00
  • CLMB $136.00
  • AVG Volume (30 Days)
  • PRTC 11.0K
  • CLMB 29.0K
  • Earning Date
  • PRTC 04-28-2025
  • CLMB 04-30-2025
  • Dividend Yield
  • PRTC N/A
  • CLMB 0.64%
  • EPS Growth
  • PRTC N/A
  • CLMB 49.27
  • EPS
  • PRTC N/A
  • CLMB 4.06
  • Revenue
  • PRTC $468,000.00
  • CLMB $465,607,000.00
  • Revenue This Year
  • PRTC N/A
  • CLMB $7.10
  • Revenue Next Year
  • PRTC $160.00
  • CLMB $8.00
  • P/E Ratio
  • PRTC N/A
  • CLMB $26.22
  • Revenue Growth
  • PRTC N/A
  • CLMB 32.27
  • 52 Week Low
  • PRTC $13.30
  • CLMB $49.70
  • 52 Week High
  • PRTC $32.98
  • CLMB $145.00
  • Technical
  • Relative Strength Index (RSI)
  • PRTC 47.62
  • CLMB 45.06
  • Support Level
  • PRTC $13.30
  • CLMB $104.34
  • Resistance Level
  • PRTC $16.75
  • CLMB $108.38
  • Average True Range (ATR)
  • PRTC 0.98
  • CLMB 5.74
  • MACD
  • PRTC -0.03
  • CLMB 0.73
  • Stochastic Oscillator
  • PRTC 51.39
  • CLMB 74.48

About PRTC PureTech Health plc

PureTech Health PLC is a biopharma company developing medicines to modulate the adaptive human system. It is a cross-disciplinary healthcare company developing products that could improve the lives of patients. The company is focused on developing and commercializing highly differentiated medicines for devastating diseases, including inflammatory, fibrotic, and immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological & neuropsychological disorders, among others. It operates in the following segments: Wholly-Owned Programs, Controlled Founded Entities, and Parent Companies & Others. The company has a robust pipeline of advanced programs that are post-human proof of concept and focused on some of society's healthcare needs.

About CLMB Climb Global Solutions Inc.

Climb Global Solutions Inc is a cloud-based, value-added IT distribution and solutions company specializing in emerging technologies. It operates across the USA, Canada, and Europe through multiple business units, including Climb Channel Solutions, Sigma, Grey Matter, Interwork, and TechXtend. The Company is organized into two reportable operating segments. The Distribution segment distributes technical software to corporate resellers, value-added resellers (VARs), consultants, and systems integrators under the name Climb Channel Solutions. The Solutions segment is a cloud solutions provider and value-added reseller of software, hardware, and services to customers under the name Grey Matter.

Share on Social Networks: